Works matching IS 00071188 AND DT 2023 AND VI 180 AND IP 3

Results: 9

Guidance for the use and reporting of anaesthetic agents in BJP manuscripts involving work with animals.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 255, doi. 10.1111/bph.15992

By:

Ingrande, Jerry;
Patel, Hemal H.;
Kendall, Dave;
Stefanska, Barbara;
Alexander, Steve;
Bakhle, Mick;
Cirino, Giuseppe;
Docherty, James R.;
George, Christopher H.;
Insel, Paul A.;
Ji, Yong;
King, Brian F.;
Lilley, Elliot;
Panettieri, Reynold A.;
Ramage, Andrew G.;
Sobey, Christopher G.;
Stanford, S. Clare;
Stephens, Gary;
Teixeira, Mauro;
Vergnolle, Nathalie

Publication type:

Article

Recent therapeutic approaches to cystathionine beta‐synthase‐deficient homocystinuria.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 264, doi. 10.1111/bph.15991

By:

Majtan, Tomas;
Kožich, Viktor;
Kruger, Warren D.

Publication type:

Article

Hypothesis: Efficacy of early treatments with some NSAIDs in COVID‐19: Might it also depend on their direct and/or indirect zinc chelating ability?

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 279, doi. 10.1111/bph.15989

By:

Zamai, Loris

Publication type:

Article

Cannabinoid 1 (CB<sub>1</sub>) receptor arrestin subtype‐selectivity and phosphorylation dependence.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 369, doi. 10.1111/bph.15973

By:

Manning, Jamie J.;
Rawcliffe, Gabriel;
Finlay, David B.;
Glass, Michelle

Publication type:

Article

Aberrant branched‐chain amino acid accumulation along the microbiota–gut–brain axis: Crucial targets affecting the occurrence and treatment of ischaemic stroke.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 347, doi. 10.1111/bph.15965

By:

Shen, Jiajia;
Guo, Huimin;
Liu, Shijia;
Jin, Wei;
Zhang, Zhi‐Wei;
Zhang, Yong;
Liu, Keanqi;
Mao, Shuying;
Zhou, Zhihao;
Xie, Lin;
Wang, Guangji;
Hao, Haiping;
Liang, Yan

Publication type:

Article

Asebogenin suppresses thrombus formation via inhibition of Syk phosphorylation.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 287, doi. 10.1111/bph.15964

By:

Li, Li;
Xu, Xulin;
Lv, Keyu;
Zheng, Guijuan;
Wang, Hao;
Chen, Shuai;
Huang, Lang;
Liu, Yi;
Zhang, Yadong;
Tang, Zhaoming;
Zhang, Lili;
Wang, Jinyu;
Qiao, Jianlin;
Li, Hongliang;
Wang, Xuanbin;
Yao, Guangmin;
Fang, Chao

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2023, v. 180, n. 3, p. 253, doi. 10.1111/bph.15871
Publication type:: Article

Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS/NF‐κB/ferroptosis pathway.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 308, doi. 10.1111/bph.15961

By:

Gao, Jianmei;
Ma, Congjian;
Xia, Dianya;
Chen, Nana;
Zhang, Jianyong;
Xu, Fan;
Li, Fei;
He, Yuqi;
Gong, Qihai

Publication type:

Article

Targeted delivery of triptolide by dendritic cell‐derived exosomes for colitis and rheumatoid arthritis therapy in murine models.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 3, p. 330, doi. 10.1111/bph.15958

By:

Rao, Quan;
Ma, Guangchao;
Li, Meng;
Wu, Hao;
Zhang, Yixi;
Zhang, Congen;
Ma, Zhijie;
Huang, Luqi

Publication type:

Article